Metastatic Squamous Cell Carcinoma of the Lung: ASCO Tumor Boards

This is a case-based activity that includes discussion of a 63 year old woman with a history of hypertension who presents to her primary care physician with a two-month history of shortness of breath on moderate exertion and a dry cough. The patient is a current one pack per day cigarette smoker for the past 32 years. A chest x-ray and CT scan of the chest and upper abdomen show a 4.2 cm right lower lobe central lung mass, subcarinal lymphadenopathy, and several liver lesions concerning for metastases. A CT-guided biopsy of the liver lesion is performed, showing squamous cell carcinoma.

Learning Objectives

  • Describe the role of first-line systemic therapy for patients with metastatic lung squamous cell carcinomas
  • Recognize options for the treatment of relapsed/refractory squamous cell carcinoma of the lung
  • Analyze the role of novel approaches including immunotherapy and targeted therapies in lung squamous cell carcinoma

Continuing Education Credit

1 Credit/Point is available for participation in this course. Certificate and credit types available includes:

  • AMA PRA Category 1 Credits™ credit

Important Notes

This course expires on February 17, 2019. Participants must complete all necessary course components by this date.

This course is available as part of the 2016 ASCO Tumor Boards bundle.